Strengthening Pharmacovigilance and Clinical Trials Oversight Capacities Through the VaccTrain Project: Achievements and Lessons Learned from LMICs in Africa
The VaccTrain Project successfully strengthened clinical trials oversight and pharmacovigilance systems in sub-Saharan African countries between 2018 and 2025 by developing WHO-aligned regulatory frameworks, enhancing operational capacities, and fostering regional collaboration, thereby demonstrating a sustainable model for improving regulatory resilience in resource-constrained settings.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine a world where a new medicine is discovered, but the people who need it most cannot trust that it is safe, or where a clinical trial is conducted so poorly that the results tell doctors nothing useful. This is the reality in many parts of the world where resources are scarce. When scientists test a new vaccine or drug, they must follow strict rules to ensure the people participating are safe and the data collected is honest. This process is called clinical trials oversight. Once a medicine is released to the public, doctors and patients must be able to report any unexpected side effects quickly so that authorities can act. This safety monitoring is known as pharmacovigilance. Without strong systems to manage these two tasks, countries risk wasting time on bad research and failing to protect their citizens from harmful drugs. The question facing public health officials in Africa has been how to build these systems from the ground up in places where funding and expertise are limited.
A team of researchers and regulators from Germany and several African nations set out to answer this question through a long-term partnership called the VaccTrain project. Their work focused on helping national regulatory authorities in countries like Sierra Leone, Liberia, The Gambia, Ghana, Zimbabwe, Rwanda, and Senegal build the capacity to oversee clinical trials and monitor vaccine safety. The project did not simply hand out manuals or hold one-off lectures. Instead, it worked side-by-side with local officials for years, helping them write their own laws, create step-by-step guides for their staff, and practice the actual work of reviewing trial applications and investigating safety reports. The goal was to move these countries from having no system or a broken one to having a functioning, reliable system that could protect people during both normal times and health emergencies.
The researchers found that this hands-on approach yielded concrete results. Between 2018 and 2025, the project helped partner countries develop or completely rewrite 185 documents related to safety monitoring and 79 documents related to clinical trial oversight. These were not just theoretical papers; they included the actual laws, rules, and standard operating procedures that government agencies use every day to approve trials and check on drug safety. The work was aligned with global standards set by the World Health Organization, ensuring that the systems built in Africa would be recognized and respected internationally. By the end of the project, the participating countries had moved from reacting to problems as they arose to having proactive systems in place that could anticipate and manage risks before they became crises.
The true test of these new systems was not just in the paperwork, but in how they functioned in the real world. The data showed a clear upward trend in activity. Countries that had previously reviewed almost no clinical trial applications began reviewing them regularly. The number of inspections to ensure trials were conducted safely increased. Perhaps most importantly, the number of reports coming in about side effects from vaccines and medicines grew significantly. In Sierra Leone, for example, the reporting of adverse events jumped dramatically in 2025, suggesting that doctors and patients were finally trusting the system enough to speak up. This increase in reporting is a sign of a healthy system, because it means the safety net is actually catching the problems it is designed to find.
A key part of the project's success was its focus on regional cooperation rather than isolated national efforts. The researchers helped establish networks where regulators from different countries could learn from one another. They created a "train-the-trainer" model, where a small group of officials received intensive training in Germany and then returned home to teach their colleagues. This created a ripple effect of knowledge that spread across the region. The project also worked closely with regional bodies and international organizations to ensure that the rules in one country matched the rules in another, making it easier to share data and rely on each other's decisions. This collaboration helped countries avoid duplicating work and allowed them to pool their limited resources more effectively.
The path to these achievements was not without significant hurdles. The global pandemic caused by COVID-19 disrupted the project, preventing in-person meetings and forcing the team to adapt to online communication, which was difficult in areas with unstable internet connections. The pandemic also placed immense pressure on the local regulators, who were overwhelmed with emergency response duties, leaving them less time for the long-term building of their systems. Despite these challenges, the project persisted. The team learned that trust takes time to build and that sustainable change requires continuous investment. They found that while technical skills are essential, the most critical factor is the commitment of the local institutions to own and maintain these systems once the external support ends.
The paper concludes that the combination of long-term partnership, practical training, and regional collaboration offers a viable model for strengthening health systems in resource-limited settings. The work demonstrates that it is possible to build robust regulatory frameworks that are both locally adapted and globally aligned. The systems established through the VaccTrain project are now better prepared to handle future public health emergencies, ensuring that when new vaccines or medicines are needed, they can be tested and monitored safely and efficiently. The findings suggest that with sustained effort and international cooperation, the gap in regulatory capacity between wealthy and poorer nations can be narrowed, ultimately saving lives and ensuring that everyone has access to safe, effective medical treatments.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.